| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |